SYRE
Spyre Therapeutics, Inc. Common Stock ·
—
Market cap
—
52-week range
—
Volume
—
Previous close
—
Spyre Therapeutics, Inc. Common Stock (SYRE) is held by 4 tracked hedge fund(s). Largest tracked holder: RTW INVESTMENTS, LP.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP RTW INVESTMENTS, LP |
2.1% | 4.2M | $210M | — | $23.64 | 2026-03-31 |
| Driehaus Capital Management LLC Driehaus Capital Management LLC |
1.0% | 2.8M | $141M | ▼ 3.2% (−92K) | $25.68 | 2026-03-31 |
| BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP |
0.3% | 1.0M | $50M | — | $15.64 | 2026-03-31 |
| Carlyle Group Inc. Carlyle Group Inc. |
0.0% | 10K | $485K | — | $21.78 | 2026-03-31 |
FAQ ▾
Which hedge funds hold SYRE?
Tracked holders include: RTW INVESTMENTS, LP, Driehaus Capital Management LLC, BAKER BROS. ADVISORS LP, Carlyle Group Inc..
How much smart money owns SYRE?
4 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading SYRE?
No tracked Congressional trades in SYRE on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.